|
2024
|
Invention
|
Tamper resistant dosage forms. The present invention relates to pharmaceutical dosage forms, for ... |
|
|
Invention
|
Tamper resistant dosage forms.
The present invention relates to pharmaceutical dosage forms, for... |
|
|
Invention
|
Sleep disorder treatment and prevention.
The disclosure relates to methods for treating or preve... |
|
|
Invention
|
Abuse deterrent morphine sulfate dosage forms.
The present invention relates to a solid oral ext... |
|
|
Invention
|
Sunobinop for use in method of treating alcohol use disorder. This disclosure relates to methods ... |
|
|
P/S
|
Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disor... |
|
|
Invention
|
Combination comprising a glucocorticoid and edo-s101.
The present invention is directed to a com... |
|
|
Invention
|
Pharmaceutical dosage forms.
The invention relates to a solid dosage form comprising a core-shel... |
|
|
Invention
|
Pharmaceutical combinations for treating cancer.
The present invention is directed to a combinat... |
|
|
Invention
|
Method of treatment and dosage forms thereof.
The invention provides an oral dosage form compris... |
|
|
Invention
|
Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
Disclosed i... |
|
|
Invention
|
Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia.
There is provided ti... |
|
|
Invention
|
Combinations for treating cancer.
The present invention relates to the use of tinostamustine or ... |
|
|
Invention
|
Pharmaceutical dosage forms.
The invention relates to a solid oral extended release pharmaceutic... |
|
|
Invention
|
Encased tamper resistant controlled release dosage forms.
In certain embodiments, the present in... |
|
|
Invention
|
Tinostamustine for use in treating ovarian cancer.
There is provided tinostamustine or a pharmac... |
|
2023
|
Invention
|
Compositions and methods for opioid antagonist delivery.
Disclosed in certain embodiments is a p... |
|
|
Invention
|
Compounds for treating tnbc. There is provided tinostamustine or a pharmaceutically acceptable sa... |
|
|
Invention
|
Treatment and prevention of sleep disorders.
The disclosure relates to methods for treating or p... |
|
|
Invention
|
Methods of treating or preventing overactive bladder syndrome. The disclosure provides a method o... |
|
|
Invention
|
Compositions and methods for opioid antagonist delivery. Disclosed in certain embodiments is a ph... |
|
|
Invention
|
Tinostamustine for use in treating sarcoma. There is provided tinostamustine or a pharmaceuticall... |
|
|
Invention
|
Encased tamper resistant controlled release dosage forms. In certain embodiments, the present inv... |
|
|
Invention
|
Tamper resistant pharmaceutical formulations.
Disclosed in certain embodiments is a solid oral d... |
|
|
Invention
|
Sleep disorder treatment and prevention. The disclosure relates to methods for treating or preven... |
|
2022
|
Invention
|
Pharmaceutical combinations for treating cancer. The present invention is directed to a combinati... |
|
|
Invention
|
Morphinan derivatives and use thereof. 3, X, and n are defined as set forth in the specification.... |
|
|
Invention
|
Combination comprising a glucocorticoid and edo-s101. The present invention is directed to a comb... |
|
|
Invention
|
Compositions and methods for levodopa delivery.
A pharmaceutical composition to treat Parkinson'... |
|
|
Invention
|
Compositions and methods for levodopa delivery. A pharmaceutical composition to treat Parkinson's... |
|
|
Invention
|
Methods and compositions particularly for treatment of attention deficit disorder.
There is desc... |
|
|
Invention
|
Compounds for treating brain cancer.
There is provided a compound of formula I or a pharmacologi... |
|
|
Invention
|
Methods of treating interstitial cystitis/bladder pain syndrome.
The disclosure provides a metho... |
|
|
Invention
|
Methods of treating interstitial cystitis/bladder pain syndrome. The disclosure provides a method... |
|
|
Invention
|
Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia. T-PLL Therapy There i... |
|
|
P/S
|
Pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdo... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceuticals. Pharmaceutical research and development. |
|
|
Invention
|
Trace amine associated receptor 1 agonists and partial agonists for pain treatment.
This applica... |
|
|
Invention
|
Methods and compositions particularly for treatment of attention deficit disorder. There is descr... |
|
2021
|
P/S
|
A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of cent... |
|
|
Invention
|
Compositions and methods for levodopa delivery.
Disclosed in certain embodiments is a method of ... |
|
|
Invention
|
Compositions and methods for levodopa delivery. Disclosed in certain embodiments is a method of t... |
|
|
Invention
|
Etoposide toniribate formulation. A liquid pharmaceutical formulation comprising etoposide toniri... |
|
|
Invention
|
Compositions and methods for emergency rescue.
Disclosed in certain embodiments is a parenteral ... |
|
|
Invention
|
Compositions and methods for naloxone delivery.
Disclosed in certain embodiments is a formulatio... |
|
2020
|
Invention
|
Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound.
Provided herein... |
|
2019
|
Invention
|
Compounds for treating lymphoma or a t-cell malignant disease.
The invention relates to tinostam... |
|
|
Invention
|
Compounds for treating multiple myeloma.
The invention relates to tinostamustine for use in the ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system disorders |
|
2018
|
P/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous sy... |
|
2014
|
P/S
|
Analgesics |
|
2010
|
P/S
|
Providing information regarding pharmaceutical products and healthcare in general via the Internet |
|
2003
|
P/S
|
Informational services, namely providing information via a global computer network regarding phar... |
|
2000
|
P/S
|
ANALGESIC PREPARATIONS |
|
|
P/S
|
BROCHURES AND INFORMATION SHEETS IN THE MEDICAL AND HEALTHCARE FIELDS |
|
1996
|
P/S
|
analgesic preparation |
|
1993
|
P/S
|
educational material for the medical profession; namely, brochures in the field of pain management |
|
1992
|
P/S
|
preparation for the relief of pain |
|
1983
|
P/S
|
Analgesic Preparation |
|
1932
|
P/S
|
MEDICAL COMPOUND FOR THE ALLEVIATION OF PAIN AND COUGH |
